{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Penicillin+G+potassium&page=3", "query": { "intervention": "Penicillin G potassium", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 173, "total_pages": 18, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Penicillin+G+potassium&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Penicillin+G+potassium&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-02T02:58:07.614Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03660488", "title": "Cefixime for Alternative Syphilis Treatment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Syphilis", "Early Syphilis" ], "interventions": [ { "name": "Cefixime 400 milligram Oral Capsule [Suprax]", "type": "DRUG" }, { "name": "Benzathine Penicillin G", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, Los Angeles", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 58, "start_date": "2018-09-03", "completion_date": "2021-01-30", "has_results": true, "last_update_posted_date": "2022-07-26", "last_synced_at": "2026-10-02T02:58:07.614Z", "location_count": 10, "location_summary": "Beverly Hills, California • Los Angeles, California • Oakland, California + 3 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03660488" }, { "nct_id": "NCT00377260", "title": "Acute Otitis Media (AOM) Therapy Trial in Young Children", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Acute Otitis Media" ], "interventions": [ { "name": "amoxicillin-clavulanate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Pittsburgh", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "23 Months", "sex": "ALL", "summary": "6 Months to 23 Months" }, "enrollment_count": 291, "start_date": "2006-11", "completion_date": "2009-04", "has_results": true, "last_update_posted_date": "2016-12-05", "last_synced_at": "2026-10-02T02:58:07.614Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00377260" }, { "nct_id": "NCT02554383", "title": "Efficacy of Antibiotics in Children With Acute Sinusitis: Which Subgroups Benefit?", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Sinusitis", "Respiratory Tract Infections" ], "interventions": [ { "name": "Amoxicillin-clavulanate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nader Shaikh", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "2 Years to 11 Years" }, "enrollment_count": 515, "start_date": "2016-02", "completion_date": "2023-03-09", "has_results": true, "last_update_posted_date": "2023-06-29", "last_synced_at": "2026-10-02T02:58:07.614Z", "location_count": 6, "location_summary": "Bardstown, Kentucky • Gresham, Oregon • Philadelphia, Pennsylvania + 3 more", "locations": [ { "city": "Bardstown", "state": "Kentucky" }, { "city": "Gresham", "state": "Oregon" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Morgantown", "state": "West Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02554383" }, { "nct_id": "NCT03485950", "title": "Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Other Infectious Diseases" ], "interventions": [ { "name": "Cefepime", "type": "DRUG" }, { "name": "Ceftolozane", "type": "DRUG" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Meropenem", "type": "DRUG" }, { "name": "Piperacillin-Tazobactam", "type": "DRUG" }, { "name": "Tazobactam", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2018-05-16", "completion_date": "2022-02-16", "has_results": true, "last_update_posted_date": "2022-03-15", "last_synced_at": "2026-10-02T02:58:07.614Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03485950" }, { "nct_id": "NCT00643292", "title": "A Single, High-Dose Azithromycin Extended Release (60 mg/kg) Compared With 10 Days of High-Dose Amoxicillin Clavulanate in Children With Ear Infections at High Risk of Persistent/Recurrent Ear Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acute Otitis Media" ], "interventions": [ { "name": "amoxicillin/clavulanate postassium (Augmentin ES-600)", "type": "DRUG" }, { "name": "azithromycin SR", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Months", "maximum_age": "48 Months", "sex": "ALL", "summary": "3 Months to 48 Months" }, "enrollment_count": 902, "start_date": "2003-01", "completion_date": "2004-05", "has_results": false, "last_update_posted_date": "2011-05-17", "last_synced_at": "2026-10-02T02:58:07.614Z", "location_count": 23, "location_summary": "Jonesboro, Arkansas • Little Rock, Arkansas • Bellflower, California + 18 more", "locations": [ { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Bellflower", "state": "California" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Fresno", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00643292" }, { "nct_id": "NCT01433757", "title": "Ampicillin for DYT-1 Dystonia Motor Symptoms", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "DYT-1", "Dystonia" ], "interventions": [ { "name": "Ampicillin", "type": "DRUG" }, { "name": "Sugar pill", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "7 Years to 80 Years" }, "enrollment_count": 2, "start_date": "2011-09", "completion_date": "2017-06", "has_results": false, "last_update_posted_date": "2017-07-05", "last_synced_at": "2026-10-02T02:58:07.614Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01433757" }, { "nct_id": "NCT01825408", "title": "Duration of Antibiotic Therapy as Part of Maximal Medical Therapy for Chronic Rhinosinusitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Sinusitis" ], "interventions": [ { "name": "Doxycycline", "type": "DRUG" }, { "name": "Azithromycin", "type": "DRUG" }, { "name": "Augmentin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 40, "start_date": "2013-02", "completion_date": "2014-06", "has_results": true, "last_update_posted_date": "2017-04-04", "last_synced_at": "2026-10-02T02:58:07.614Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01825408" }, { "nct_id": "NCT02099240", "title": "Patients Response to Early Switch To Oral:Osteomyelitis Study", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Osteomyelitis" ], "interventions": [ { "name": "oral antibiotics", "type": "DRUG" }, { "name": "intravenous antibiotics", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Julio Ramirez", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 11, "start_date": "2014-03-06", "completion_date": "2018-11-07", "has_results": false, "last_update_posted_date": "2021-04-06", "last_synced_at": "2026-10-02T02:58:07.614Z", "location_count": 1, "location_summary": "Louisville, Kentucky", "locations": [ { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT02099240" }, { "nct_id": "NCT04198129", "title": "The Evaluation of Postoperative Antibiotics in Non-Infected Mandible Fractures", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Jaw Fractures", "Infection" ], "interventions": [ { "name": "Antibiotic treatment (Unasyn or Cleocin)", "type": "DRUG" }, { "name": "Antibiotic treatment (Augmentin or Cleocin)", "type": "DRUG" }, { "name": "Control Group", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "The University of Texas Health Science Center, Houston", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 13, "start_date": "2020-10-01", "completion_date": "2022-03-20", "has_results": false, "last_update_posted_date": "2025-06-26", "last_synced_at": "2026-10-02T02:58:07.614Z", "location_count": 2, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04198129" }, { "nct_id": "NCT01110382", "title": "A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Abscess, Intra-Abdominal", "Abdominal Abscess", "Abdomen, Acute", "Abdominal Pain", "Appendicitis", "Rupture", "Infection", "Intestinal Perforation", "Peritonitis", "Ileus" ], "interventions": [ { "name": "Doripenem", "type": "DRUG" }, { "name": "Meropenem placebo", "type": "DRUG" }, { "name": "Meropenem", "type": "DRUG" }, { "name": "Doripenem placebo", "type": "DRUG" }, { "name": "Amoxicillin/clavulanate potassium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Months", "maximum_age": "18 Years", "sex": "ALL", "summary": "3 Months to 18 Years" }, "enrollment_count": 41, "start_date": "2010-12", "completion_date": "2013-09", "has_results": true, "last_update_posted_date": "2014-07-15", "last_synced_at": "2026-10-02T02:58:07.614Z", "location_count": 4, "location_summary": "San Diego, California • Washington D.C., District of Columbia • Cleveland, Ohio + 1 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Toledo", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01110382" } ] }